management of urolitheasis with ayurvedic medicine

Effect of tilakshara in the management of mutrashmari

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/04/018359

Enrollment

Registered

2019-04-01

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N202- Calculus of kidney with calculus of ureter

Interventions

Intervention1: TILA KSHARA: tila kshar is preparared by classical method in lab and filled in capsules of 250 mg and given in dose of 1 bd Control Intervention1: not applicable : not applicable

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients with size of the calculi less than 10 mm. 2 Unilateral, Bilateral and multiple maximum 4 calculus.

Exclusion criteria

Exclusion criteria: 1 Pyelonephritis 2 Patient having Gross hydronephrosis. 3 Poorly functioning kidney 4 Patients with obstruction in urinary passage 5 In case, Patient requires immediate surgical intervention. 6 Chronic systemic illness, Uncontrolled DM and HTN, HIV positive malignancy, TB 7 Pregnant & Lactating women

Design outcomes

Primary

Measure	Time frame
reduction in size of stoneTimepoint: 1 month	—

Secondary

Measure	Time frame
no renal colicTimepoint: 15 days	—

Countries

India

Contacts

Public ContactMukesh kumar

parul institute of ayurved

drhemantt@gmail.com8469496525

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026